The store will not work correctly when cookies are disabled.
Alizarin Red S
ID: ALA1206015
Cas Number: 27613-78-1
PubChem CID: 8534
Max Phase: Preclinical
Molecular Formula: C14H8O7S
Molecular Weight: 320.28
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1c2ccccc2C(=O)c2c1cc(S(=O)(=O)O)c(O)c2O
Standard InChI: InChI=1S/C14H8O7S/c15-11-6-3-1-2-4-7(6)12(16)10-8(11)5-9(22(19,20)21)13(17)14(10)18/h1-5,17-18H,(H,19,20,21)
Standard InChI Key: JKYKXTRKURYNGW-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
5.9958 -4.6708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4250 -5.4958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1375 -5.9083 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.9958 -5.4958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2792 -4.2583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7083 -4.2583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4250 -4.6708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2792 -5.9083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5667 -4.6708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5667 -5.4958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7083 -5.9083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8542 -6.3208 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5500 -5.1958 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2792 -3.4333 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2792 -6.7333 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7250 -6.6208 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7083 -3.4333 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1375 -4.2583 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8500 -4.2583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8500 -5.9083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1375 -5.4958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1375 -4.6708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 7 1 0
3 2 1 0
4 1 2 0
5 1 1 0
6 1 1 0
7 6 2 0
8 4 1 0
9 5 1 0
10 9 2 0
11 4 1 0
12 3 2 0
13 3 2 0
14 5 2 0
15 8 2 0
16 3 1 0
17 6 1 0
18 7 1 0
19 9 1 0
20 10 1 0
21 22 1 0
22 19 2 0
11 2 2 0
10 8 1 0
21 20 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 320.28 | Molecular Weight (Monoisotopic): 319.9991 | AlogP: 1.12 | #Rotatable Bonds: 1 |
Polar Surface Area: 128.97 | Molecular Species: ACID | HBA: 6 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: -2.80 | CX Basic pKa: ┄ | CX LogP: 2.79 | CX LogD: 0.32 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.45 | Np Likeness Score: 0.56 |
References
1. Wang P, Jiang L, Cao Y, Zhang X, Chen B, Zhang S, Huang K, Ye D, Zhou L.. (2018) Xanthone derivatives as phosphoglycerate mutase 1 inhibitors: Design, synthesis, and biological evaluation., 26 (8): [PMID:29530347] [10.1016/j.bmc.2018.02.044] |